TRINITY BIOTECH PLC
For the period ended Dec 31, 2023. Filed Apr 30, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Apr 30, 2024
Contents
Item 16B. Code of Ethics
| 16 B. | Code of Ethics |
|---|
Trinity Biotech has adopted a code of ethics that applies to the Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and all organisation employees. Written copies of the code of ethics are available free of charge upon written request to us at the address on the first page of this annual report. If we make any substantive amendments to the code of ethics or grant any waivers, including any implicit waiver, from a provision of these codes to our Chief Executive Officer, Chief Financial Officer or Chief Accounting Officer, we will disclose the nature of such amendment or waiver on our website.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.